SRDXSurmodics, Inc.

SRDX Stock Price, Valuation & Chart | Surmodics, Inc.

Compare

$42.980+0.15 (+0.35%)

At close · 25 Nov 2025, 02:30 pm

Sector: Healthcare Industry: Medical - Devices SRDX intrinsic value SRDX calculated fair value vs price

Overview Financials Dividends Ratios

SRDX Historical price chart

SRDX Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization614.51M

PE Ratio-34.66

EPS-1.24

Trading Volume5.34M

Today's High/Low42.98/42.98

Dividend Yield0.00

52 Week High/Low43.0/25.87

Shares Outstanding14.30M

SRDX Financial Statement

SRDX Analyst ratings

SRDX Analysis & performance metrics

SRDX Company profile

Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic…

Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface…

SRDX Management team

Name

Position

Charles W. Olson

Senior Vice President & President of Medical Device Coatings

Gordon S. Weber J.D.

Senior Vice President of Legal, General Counsel & Secretary

Joseph J. Stich

Senior Vice President of Human Resources & President of In Vitro Diagnostics

John D. Manders

Corporate Controller, Vice President of Finance & Principal Accounting Officer

Joel SuiterCTO

Director of Corporate Development

Gary R. MaharajCEO

Chief Executive Officer, President & Director

Teryl L. W. Sides

Senior Vice President & President of Vascular Interventions

Timothy J. ArensCFO

Senior Vice President of Finance & Information Technology and Chief Financial Officer

Name

Position

Charles W. Olson

Senior Vice President & President of Medical Device Coatings

Gordon S. Weber J.D.

Senior Vice President of Legal, General Counsel & Secretary

Joseph J. Stich

Senior Vice President of Human Resources & President of In Vitro Diagnostics

John D. Manders

Corporate Controller, Vice President of Finance & Principal Accounting Officer

Joel SuiterCTO

Director of Corporate Development

Gary R. MaharajCEO

Chief Executive Officer, President & Director

Teryl L. W. Sides

Senior Vice President & President of Vascular Interventions

Timothy J. ArensCFO

Senior Vice President of Finance & Information Technology and Chief Financial Officer

Management Team

Charles W. Olson

Senior Vice President & President of Medical Device Coatings

Gordon S. Weber J.D.

Senior Vice President of Legal, General Counsel & Secretary

Joseph J. Stich

Senior Vice President of Human Resources & President of In Vitro Diagnostics

John D. Manders

Corporate Controller, Vice President of Finance & Principal Accounting Officer

Joel SuiterCTO

Director of Corporate Development

Gary R. MaharajCEO

Chief Executive Officer, President & Director

Teryl L. W. Sides

Senior Vice President & President of Vascular Interventions

Timothy J. ArensCFO

Senior Vice President of Finance & Information Technology and Chief Financial Officer

Management

Charles W. Olson

Senior Vice President & President of Medical Device Coatings

Gordon S. Weber J.D.

Senior Vice President of Legal, General Counsel & Secretary

Joseph J. Stich

Senior Vice President of Human Resources & President of In Vitro Diagnostics

John D. Manders

Corporate Controller, Vice President of Finance & Principal Accounting Officer

Joel SuiterCTO

Director of Corporate Development

Gary R. MaharajCEO

Chief Executive Officer, President & Director

Teryl L. W. Sides

Senior Vice President & President of Vascular Interventions

Timothy J. ArensCFO

Senior Vice President of Finance & Information Technology and Chief Financial Officer

Total 8 executives

SRDX Frequently asked questions

What is Surmodics, Inc. (SRDX) Stock Price?

Current stock price of Surmodics, Inc. (SRDX) stock is $42.980. The stock price is +0.35% higher in the session. The intraday range can be seen from this page. Volume of Surmodics, Inc. (SRDX) stock is 5.34M.

Last updated at 25 Nov 2025, 02:30 pm.

Why is the Surmodics, Inc. (SRDX) stock price going up or down today?

The stock price of Surmodics, Inc. (SRDX) can change with earnings, company news, and overall market sentiment. Surmodics, Inc. operates in the Healthcare / Medical - Devices market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Surmodics, Inc. stock expensive at its current price?

Whether Surmodics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for SRDX on this page is -34.66. EPS on this page is -1.24. Compare those figures with peers and growth expectations before deciding if the current Surmodics, Inc. price is justified.

How has the stock price of Surmodics, Inc. (SRDX) performed historically?

Historical performance for Surmodics, Inc. (SRDX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how SRDX reacted to past earnings and market events.

Should I buy Surmodics, Inc. (SRDX) stock, at this price?

Buying Surmodics, Inc. (SRDX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.